ACHE and Alzheimer disease: Importantly, molecular docking studies showed that carnosic acid, rosmaric acid, and UA potentially inhibited acetylcholine esterase (AChE) and BACE1, exhibiting binding energies comparable to those of donepezil and therefore could be used to treat AD pathogenesis [77].